在肝脏疾病中转移RNA衍生的小RNA
Qin-Yuan Huang1, Zi-Yan Zhou1, Yi-Le Zhang1
1Department of Clinical Medicine, School of Medicine, Hangzhou City University, Hangzhou 310015, China.
概括
转移RNA衍生小RNAs (tsRNAs) 是细胞过程的关键调节者. 本综述详细介绍了它们在肝炎,MASLD和HCC等肝脏疾病中的改变表达,强调了它们的生物标志物和治疗潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 生物化学 生化学
背景情况:
- 转移RNA衍生的小RNAs (tsRNAs) 正在出现小的非编码RNAs.
- tsRNAs是由成熟的tRNA或前体通过酶分裂生成的.
- 它们调节关键的细胞功能,包括蛋白质合成和基因表达.
研究的目的:
- 为提供tsRNA功能特征的全面概述.
- 为了突出肝脏疾病中24个特定tsRNAs的表达变化.
- 探索tsRNAs在各种肝脏病理中的作用及其作为生物标志物和治疗点的潜力.
主要方法:
- 对肝脏疾病中tsRNAs当前研究的文献综述.
- 在诸如B/C型肝炎,酒精性肝病,MASLD/NAFLD和HCC等疾病中分析tsRNA表达特征.
- 检查tRNAs的调节机制和生物作用.
主要成果:
- 在肝脏疾病中观察到tsRNA表达的显著变化.
- 具体来说,与健康对照组相比,13个tsRNAs被发现具有上调和4个下调.
- 改变tsRNA表达有助于肝脏疾病的进展.
结论:
- tsRNAs在各种肝脏疾病的发病过程中发挥着重要作用.
- tsRNAs显示为肝脏疾病管理的诊断和预后生物标志物具有前途.
- 在肝病治疗中,tsRNAs代表了精准医学的潜在治疗点.
相关概念视频
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Small interfering RNAs (siRNA)
3.6K
3.6K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
MicroRNAs
21.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.8K
Translational Regulation
99
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
99


